Bristol Professor elected to Academy of Medical Sciences
A Professor in the Bristol Medical School has been recognised for their contribution to research in orthopaedic surgery with their election to the Fellowship of the Academy of Medical Sciences

A Professor in the Bristol Medical School has been recognised for their contribution to research in orthopaedic surgery with their election to the Fellowship of the Academy of Medical Sciences

Childhood sexual abuse (CSA) affects half a million children and young people every year. In Bristol alone, it is estimated that 13,000 children and young people are currently living with experiences of sexual abuse. In the first event of its kind, University of Bristol researchers and The Green House, Bristol’s only specialist provider of therapeutic support, are collaborating to stage a Festival to support survivors. The Beyond Therapy Festival of Activism Against Child Sexual Abuse will be held on Thursday 19 May at the Watershed.

Military men who had been present when British nuclear weapons were tested in the 1950s and 60s are no more likely to pass on to their descendants more changes to their DNA in comparison to other veterans, a new study involving University of Bristol researchers, has found.

Using inhaled antibiotics to treat lower respiratory tract infections could help reduce antimicrobial resistance, according to researchers from the Universities of Bristol and Bath.

Some public venues may need better ventilation to prevent the spread of COVID-19 following growing evidence of the potential for 'long distance' airborne transmission of the disease, suggests research published by The BMJ today [29 June].

New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with a decrease in knee replacement surgery and may be contributing to health inequalities. With one in ten people likely to need a knee replacement, many thousands of patients are directly affected by these policies.

A new collaboration to help patients with nephrotic syndrome, a type of kidney disease, has been announced today [2 March] by the University of Bristol and Evotec SE.

Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.

New research shows that lifelong excess weight almost doubles a woman’s risk of developing womb cancer*, according to a Cancer Research UK-funded study led by the University of Bristol and published today [19 April] in BMC Medicine**.

Bristol-based study Children of the 90s has helped improve understanding of the causes and treatment of long COVID.